American Journal of Infectious Diseases and Microbiology
ISSN (Print): 2328-4056 ISSN (Online): 2328-4064 Website: Editor-in-chief: Maysaa El Sayed Zaki
Open Access
Journal Browser
American Journal of Infectious Diseases and Microbiology. 2018, 6(1), 9-15
DOI: 10.12691/ajidm-6-1-2
Open AccessArticle

Transfusion Transmissible Viral Infections Risk at Two Teaching Hospitals Blood Banks in Nigeria

Osuji A1, , Agbakoba N. R.2 and Ifeanyichukwu M. O.2

1Microbiology and Immunology Department, University of Abuja Teaching Hospital, Gwagwalada, Abuja, Nigeria

2Medical Laboratory Science Department, Nnamdi Azikiwe University, Nnewi, Campus, Anambra State, Nigeria

Pub. Date: March 02, 2018

Cite this paper:
Osuji A, Agbakoba N. R. and Ifeanyichukwu M. O.. Transfusion Transmissible Viral Infections Risk at Two Teaching Hospitals Blood Banks in Nigeria. American Journal of Infectious Diseases and Microbiology. 2018; 6(1):9-15. doi: 10.12691/ajidm-6-1-2


Background/ Objectives: Transfusion Transmissible viral infections such as HIV, HBV and HCV are infectious agents that can pose a threat to blood safety. The aim of this study is to determine the prevalence and coinfection of Hepatitis B Virus (HBV), Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) among blood donors tested negative to these viruses by rapid test devices. Materials and Methods: Two hundred and twelve (212) healthy blood donors (108 and 104 from UATH and NAUTH respectively) certified fit for blood donation were recruited for this study. One hundred and nine eighty (198) samples that were seronegative for HBsAg, HIV, HCV and Syphilis by rapid test were examined for the presence of HBsAg, Anti-HCV and HIV (Ab + Ag) using 4TH generation ELISA. Qualitative conventional PCR was used to confirm ELISA positive sera for HBV DNA, HIV RNA and HCV RNA. Results: Out of 198 blood donor samples negative for HBV, HCV and HIV by rapid test, 13.7%, 13.7% and 8.1% were positive by ELISA for HBV, HIV and HCV respectively. Twelve samples (6.1%) have coinfection of TTIs. One (1) sample out of the 12 samples is co-infected with these three viral (HBV, HCV and HIV) agents. Of the 28 samples positive for HBV by ELISA, 20 (71.4%) were positive for HBV DNA, 8 (36.4%) of 22 positive samples by HIV ELISA were positive for HIV RNA and 4 (28.6%) of 14 samples were positive for HCV RNA (p=0.0001). Conclusion and Recommendations: There is a high prevalence of transfusion transmissible viral infections among blood donors at our study population. This study therefore recommends blood donors in these Hospitals in particular and Nigeria in general be screened for HIV, HCV and HBsAg using ELISA 4th generation test kits and Nucleic Acid Testing (NAT).

blood donors screening transfusion transmissible viral infections

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit


[1]  World Health Organization (2009a) Hepatitis B Fact sheet No 204. Accessed 10 June 2009. Available:
[2]  Dodd RY (2007). Current risk for transfusion-transmitted infections. Current Opinion in Hematology. 14(6): 671-676.
[3]  Panda M Kar K (2008). HIV, hepatitis B and C infection status of the blood donors in a blood bank of a tertiary health care centre of Orissa. Indian Journal of Public Health. 52(1): 43-44.
[4]  World Health Organization (2008). Global Database on Blood Safety, 2004–2005 report. Geneva, World Health Organization, 2008.
[5]  Acheson NH (2011). Fundamentals of Molecular Virology. 2nd Ed. John Wiley and Sons Inc. USA. Pages 365-375.
[6]  Asim M Ali R Khan LA Husain SA Singla R Kar P. (2010). Significance of anti-HBc screening of blood donors and its association with occult hepatitis B Virus infection: Implications for blood transfusion. Indian Journal of Medical Research. 132: 312-317. Sept 2010.
[7]  Baba MM Hassan AW Gashau W (2010). Prevalence of hepatitis B antigenaemia and Human Immunodeficiency Virus in blood donors in Maiduguri, Nigeria. Nigerian Journal of Medicine. 9: 10-12.
[8]  Okwesili A Usman I Abubakar W Onuigue F Erhabor O Buhari H Abdulrahaman Y Isaac Z Mainasara Y Aghedo F Ikhuenbor D Mohammed H Y Dallatu K Mainasara A Gwarzo S (2014). Prevalence of Transfusion -Transmissible Hepatitis B Infection among Blood Donors in Sokoto, North Western, Nigeria. Health Sciences Research. 1(4): 113-118.
[9]  Olokoba AB Salawu FK Danburam A Desalu OO Olokoba LB Wahab KW Badung LH Tidi SK Midala J Aderibigbe S Abdulrahman MB Babalola OM Abdukkarim A (2009). Viral Hepatitis in Voluntary Blood Donors in Yola, Nigeria. European Journal of Scientific Research. 31 (3): 329-334.
[10]  Ndako JA Nwankiti OO Echeonwu GON Junaid SA Anaele O Anthony TJ (2011). Studies on Prevalence and Risk Factors for Hepatitis B Surface Antigen among Secondary School Students in North-central, Nigeria. Sierra Leone Journal of Biomedical Research. 3 (3): 163-168.
[11]  Badur S Akgun A (2001). Diagnosis of Hepatitis B Infection and monitoring of Treatment. Journal of Clinical Virology. 21: 229-237.
[12]  World Health Organization (2007). Status of blood safety in the WHO African Region: Report of the 2004 Survey WHO Regional Office for Africa, Brazzaville. 2007; 1-25:25.
[13]  World Health Oorganization (2002). Safe Blood and Blood Products. Introductory Module: Guidelines and Principles for Safe Blood Transfusion Practice. Geneva, World Health Organization, 2002.
[14]  WHO (2009b). Blood Safety Indicators, 2007. Geneva, World Health Organization, 2009.
[15]  Kwok S Higushi R (1989) Avoiding false positives with PCR. Nature. 339 (6221): 237-238.
[16]  Olotu AA Oyelese AO Salawu L Audu RA Okwuraiwe AP Aboderin AO (2016). Occult Hepatitis B Virus infection in previously screened, blood donors in Ile-Ife, Nigeria: Implications for blood transfusion and stem cell transplantation. Virology Journal.13: 76-86.
[17]  Oluyinka OO Tong HV Bui Tien S Fagbami AH Adekanle O Ojurongbe O Bock CT Kremsner PG Velavan TP (2015). Occult Hepatitis B Virus Infection in Nigerian Blood Donors and Hepatitis B Virus Transmission Risks. PLoS ONE 10(7): e0131912.
[18]  Constantine NT Saville RD Dax EM (2005). Retroviral Testing and Quality Assurance Essential for Laboratory Diagnosis. 1st Ed. A non-profit supported through an educational grant from MedMira Laboratories. Pages 133-151.
[19]  Bjoerkvoll B Viet L Ol HS Lan NT Sothy S Hoel H Gutteberg T Husebekk A Larsen S Husum H (2010). Screening test accuracy among potential blood donors of HBsAg, anti-HBc and anti-HCV to detect hepatitis B and C virus infection in rural Cambodia and Vietnam. Southeast Asian Journal of Tropical Medicine and Public Health. 41(5): 1127-1135.
[20]  Akpulu SP Adamu M Oledinma S Yaro EG Ajayi IT (2017). Prevalence of Transfusion Transmissible infections among blood donors attending Hajiya Gambo Sawaba General Hospital, Zaria, Nigeria. Nigerian Biomedical Science Journal.14 (3): 24-37.
[21]  Levinson, W (2014). Review of Medical Microbiology and Immunology. 13TH Ed. McGraw Lange Medical Book, USA. Pages 331-341.
[22]  Sharma DC Rai S Bharat S Iyenger S Gupta S Sao S Jain B (2014). Transfusion Transmissible Infections among Blood Donors at the Blood Bank of Medical College of Gwalior: A 5 Year Study. International Blood Research and Reviews. 2 (5): 235-246.
[23]  Candotti D Allain JP (2009). Transfusion-transmitted hepatitis B virus infection. Journal of Hepatology. 51: 798-809.
[24]  Manzini P Girotto M Borsotti R Giachino O Guaschino R Lanteri M Testa D Ghiazza P Vacchini M Danielle F (2007). Italian blood donors with anti-HBc and occult hepatitis B virus infection. Haematologica. 92: 1664-1670.
[25]  Bouike Y Imoto S Mabuchi O Kokubunji A Kai S Okada M Taniguchi R Momose S Uchida S Nishio H (2011). Infectivity of HBV DNA positive donations identified in look-back studies in Hyogo-Prefecture, Japan. Transfusion Medicine. 21: 107-115.